Arterial baroreceptors mediate the inhibitory effect of acute increases in arterial blood pressure on thirst.
The present study sought to determine whether arterial baroreceptor afferents mediate the inhibitory effect of an acute increase in arterial blood pressure (AP) on thirst stimulated by systemically administered ANG II or by hyperosmolality. Approximately 2 wk after sinoaortic denervation, one of four doses of ANG II (10, 40, 100, or 250 ng. kg(-1) x min(-1)) was infused intravenously in control and complete sinoaortic-denervated (SAD) rats. Complete SAD rats ingested more water than control rats when infused with 40, 100, or 250 ng x kg(-1) x min(-1) ANG II. Furthermore, complete SAD rats displayed significantly shorter latencies to drink compared with control rats. In a separate group of rats, drinking behavior was stimulated by increases in plasma osmolality, and mean AP was raised by an infusion of phenylephrine (PE). The infusion of PE significantly reduced water intake and lengthened the latencies to drink in control rats but not in complete SAD rats. In all experiments, drinking behavior of rats that were subjected to sinoaortic denervation surgery but had residual baroreceptor reflex function (partial SAD rats) was similar to that of control rats. Thus it appears that arterial baroreceptor afferents mediate the inhibitory effect of an acute increase in AP on thirst stimulated by ANG II or hyperosmolality.
Stocker
Sean D
SD
Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
Stricker
Edward M
EM
Sved
Alan F
AF
D000804:Angiotensin II / Q000008:administration & dosage / Q000097:blood; D000818:Animals; D001158:Arteries / Q000502:physiology*; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology; D001645:Biguanides / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002346:Carotid Sinus / Q000502:physiology; D003714:Denervation; D004305:Dose-Response Relationship, Drug; D004327:Drinking Behavior / Q000187:drug effects / Q000502:physiology; D007262:Infusions, Intravenous; D007266:Inhibition, Psychological; D008297:Male; D009994:Osmolar Concentration; D010656:Phenylephrine / Q000008:administration & dosage; D011311:Pressoreceptors / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D013894:Thirst / Q000187:drug effects / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
D001645:Biguanides; D014665:Vasodilator Agents; D000804:Angiotensin II; D010656:Phenylephrine; C008846:phenyl biguanide